Midatech forms scientific advisory board
This article was originally published in Scrip
Abingdon, UK-based Midatech, which develops nanomedicines based on its gold-nanoparticle technology, has formed as scientific advisory board. The advisory board includes senior figures from research and industry with expertise in key areas including nanoparticles, materials chemistry, drug development and delivery, and patent protection; and will be chaired by Francesco Stellaci, Constellium professor and head of the supramolecular nanomaterials and interfaces laboratory at the École Polytechnique Fédérale de Lausanne.
You may also be interested in...
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.